In vivo modification of Abeta plaque toxicity as a novel neuroprotective lithium-mediated therapy for Alzheimer's disease pathology.
about
Six psychotropics for pre-symptomatic & early Alzheimer's (MCI), Parkinson's, and Huntington's disease modification.Dual roles of Aβ in proliferative processes in an amyloidogenic model of Alzheimer's diseasePhagocytic clearance of presynaptic dystrophies by reactive astrocytes in Alzheimer's disease.Microglia in Alzheimer's Disease: Activated, Dysfunctional or Degenerative.
P2860
In vivo modification of Abeta plaque toxicity as a novel neuroprotective lithium-mediated therapy for Alzheimer's disease pathology.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
In vivo modification of Abeta ...... Alzheimer's disease pathology.
@en
In vivo modification of Abeta ...... Alzheimer's disease pathology.
@nl
type
label
In vivo modification of Abeta ...... Alzheimer's disease pathology.
@en
In vivo modification of Abeta ...... Alzheimer's disease pathology.
@nl
prefLabel
In vivo modification of Abeta ...... Alzheimer's disease pathology.
@en
In vivo modification of Abeta ...... Alzheimer's disease pathology.
@nl
P2093
P2860
P50
P356
P1476
In vivo modification of Abeta ...... Alzheimer's disease pathology.
@en
P2093
Elisabeth Sanchez-Mejias
Ines Moreno-Gonzalez
Javier Vitorica
Jose Carlos Davila
Marisa Vizuete
Raquel Sanchez-Varo
Vanessa De Castro
Victoria Navarro
P2860
P2888
P356
10.1186/2051-5960-1-73
P50
P577
2013-11-12T00:00:00Z
P5875
P6179
1017341295